Related references
Note: Only part of the references are listed.Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008
S. Hawser et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Risk factors and outcome of extended-spectrum beta-lactamase-producing Enterobacter cloacae bloodstream infections
Zubair A. Qureshi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Klebsiella pneumoniae Strains Producing Extended-Spectrum β-Lactamases in Spain: Microbiological and Clinical Features
C. Ruiz de Alegria et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria
Yen-Hsu Chen et al.
JOURNAL OF INFECTION (2011)
Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Enterobacter cloacae: Role of Carbapenem Therapy
Ching-Chi Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Susceptibility of Gram-Negative Pathogens Isolated from Patients with Complicated Intra-Abdominal Infections in the United States, 2007-2008: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)
Daryl J. Hoban et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Community-Onset Bacteremia Due to Extended-Spectrum beta-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis
Jesus Rodriguez-Bano et al.
CLINICAL INFECTIOUS DISEASES (2010)
Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and extended-spectrum β-lactamase-non-producing Escherichia coli isolates
L. Lopez-Cerero et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain
Y. Doi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome
Carlota Gudiol et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Diversity of Escherichia coli Strains Producing Extended-Spectrum β-Lactamases in Spain: Second Nationwide Study
Miguel A. Diaz et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli
Jesus Rodriguez-Bano et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Karthikeyan K. Kumarasamy et al.
LANCET INFECTIOUS DISEASES (2010)
Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli
Jesus Rodriguez-Bano et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Breakpoints for extended-spectrum beta-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations
A. MacGowan
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam
L. R. Peterson
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Clinical significance of extended-spectrum beta-lactamases
Jesus Rodriguez-Bano et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
Predictors of mortality from community-onset bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
Anucha Apisarnthanarak et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli:: failure of automated systems to detect resistance to piperacillin/tazobactam
Johann D. D. Pitout et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Carbapenem-Resistant Enterobacteriaceae
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Extended-spectrum beta-lactamase-producing enterobacteriaceae: an emerging public-health concern
Johann D. D. Pitout et al.
LANCET INFECTIOUS DISEASES (2008)
Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15
Teresa M. Coque et al.
EMERGING INFECTIOUS DISEASES (2008)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
LANCET (2007)
Piperacillin-tazobactam for Pseudomonas aeruginosa infection:: Clinical implications of an extended-infusion dosing strategy
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2007)
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing enterobacteriaceae: Importance of inadequate initial antimicrobial treatment
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Bacteremia due to extended-spectrum β-lactamase producing Escherichia coli in the CTX-M era:: A new clinical challenge
Jesus Rodriguez-Bano et al.
CLINICAL INFECTIOUS DISEASES (2006)
Endocarditis caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae:: Emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility
Oren Zimhony et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Proteus mirabilis bloodstream infections:: Risk factors and treatment outcome related to the expression of extended-spectrum β-lactamases
A Endimiani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Antibiotic therapy for Klebsiella pneumoniae bacteremia:: Implications of production of extended-spectrum β-lactamases
DL Paterson et al.
CLINICAL INFECTIOUS DISEASES (2004)
Pharmacokinetics-pharmacodynamics of cefepime and piperacillin-tazobactam against Escherichia coli and Klebsiella pneumoniae strains producing extended-spectrum β-lactamases:: Report from the ARREST program
PG Ambrose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
MM Levy et al.
CRITICAL CARE MEDICINE (2003)
Share Paper
